| 803 | 5 | 34 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 制备黄体酮脂质体,优选黄体酮脂质体微针的处方工艺,考察黄体酮脂质体微针的体外释放及经皮渗透效果。方法 制备黄体酮脂质体,以包封率、粒径及电镜下形态进行表征。将黄体酮脂质体与微针基质材料甲基丙烯酰化明胶(GelMA)混合,采用溶剂铸造法制备微针阵列,对微针的皮肤穿刺性、载药量、体外释放、经皮渗透性能进行考察。结果 制得的黄体酮脂质体包封率为(70.88±2.07)%,粒径为(266.93±9.05) nm,聚合物分散性指数(PDI)为(0.23±0.03),72 h体外释放率为(83.58±2.54)%。黄体酮脂质体微针最优工艺为:以15%的甲基丙烯酰化明胶为微针基质,光引发剂LAP浓度为0.25%,制得微针的载药量为(329.83±3.00)μg/cm2,光固化后,微针溶胀度均在200%以上。在体外释放实验中,分别经光固化1、2、3 min的黄体酮脂质体微针释放量随光固化时间的延长而下降。在体外经皮渗透实验中,在96 h时光固化1 min的累计渗透量为(167.08±4.75)μg/cm2,光固化2 min的累计渗透量为(159.69±6.04)μg/cm2,3 min的累计渗透量为(135.47±11.34)μg/cm2。结论 优选出的黄体酮脂质体微针成型性好,机械强度高。相较于脂质体,黄体酮微针能够更加有效地经皮渗透,可改善黄体酮透皮制剂的透皮性能。
Abstract:Objective To prepare progesterone liposomes, to optimize the prescription process of progesterone liposome microneedles and to investigate the in vitro release and transdermal penetration of progesterone liposome microneedles. Methods Progesterone liposomes were prepared and characterized by encapsulation rate, particle size and morphology under electron microscopy. The progesterone liposomes were later mixed with the microneedle matrix material methacrylate-based gelatin(GelMA) to prepare microneedle arrays with using the solvent casting method to investigate the skin penetration, drug loading, in vitro release and transdermal penetration properties of the microneedles. Results The progesterone liposome encapsulation rate was(70.88±2.07)%; the particle size was(266.93±9.05) nm, the polymer dispersity index(PDI) was(0.23±0.03); the 72 h in vitro release rate was(83.58±2.54)%.The optimal technology of progesterone liposome microneedle was as follows: 15% GelMA was used as microneedle matrix, the concentration of photoinitiator LAP was 0.25%, the drug loading capacity of microneedles was(329.83±3.00) μg/cm2, and the expansion degree of microneedles was above 200% after photocurig. In vitro release experiment, the amount of progesterone lipid microneedles released by light curing for 1,2 and 3 min respectively decreased with the extension of light curing time. In vitro percutaneous permeation experiments, the cumulative amount of progesterone liposome microneedles released after 1 min of light curing at 96 h was(167.08±4.75) μg/cm2,(159.69±6.04) μg/cm2 for 2 min and(135.47±11.34) μg/cm2 for 3 min of light curing. Conclusion The preferred progesterone liposome microneedles had good formability and high mechanical strength. Compared with liposomes, progesterone microneedles can penetrate more effectively transdermally and can improve the transdermal performance of progesterone transdermal formulations.
[1] 杨通飞,李庆琼,邱璐.黄体酮临床应用现状及研究进展[J].中国现代医生,2022,60(18):220-224.
[2] BARBOSA M,VALADARES N,BARBOSA A,et al.Oral dydrogesterone vs vaginal progesterone capsules for luteal-phase support in women undergoing embryo transfer:a systematic review and meta-analysis[J].JBRA Assist Reprod,2018,22(2):148-156.
[3] BUTTS C L,BOWERS E,HORN J C,et al.Inhibitory effects of progesterone differ in dendritic cells from female and male rodents[J].Gend Med,2008,5(4):434-447.
[4] TANADA M S,YOSHIDA I H,SANTOS M,et al.The impact of high progesterone levels on the day of HCG administration in assisted human reproduction treatments[J].JBRA Assist Reprod,2018,22(2):99-101.
[5] 宋娌娜,胡巧珍.保胎饮结合黄体酮胶丸对脾肾两虚型早期先兆流产患者保胎成功率的影响[J].临床医药文献电子杂志,2020,7(53):132-134.
[6] 吴雪青,余倩,林霞,等.黄体酮阴道缓释凝胶的处方及工艺的研究[J].广州化工,2021,49(17):110-114.
[7] ROMERO R,CONDE-AGUDELO A,DA F E,et al.Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix:a meta-analysis of individual patient data[J].Am Obstet Gynecol,2018,218(2):161-180.
[8] KUROPAKORNPONG P,ITHARAT A,OORAIKUL B,et al.Development and optimization of benjakul microemulsion formulations for enhancing topical anti-inflammatory effect and delivery[J].Res Pharm Sci,2022,17(2):111-122.
[9] CUI Y,MO Y,ZHANG Q,et al.Microneedle-assisted percutaneous delivery of paeoniflorin-loaded ethosomes[J].Molecules,2018,23(12):3371.
[10] LIN Y,SHAO R,XIAO T,et al.Promotion of hair regrowth by transdermal dissolvable microneedles loaded with rapamycin and epigallocatechin gallate nanoparticles[J].Pharmaceutics,2022,14(7):1404-1409.
[11] BHADALE R S,LONDHE V Y.A systematic review of carbohydrate-based microneedles:current status and future prospects[J].Mater Sci Mater Med,2021,32(8):89-92.
[12] NURUL F A,ELIM D,SYA′BAN M M,et al.Polymeric hydrogel forming microneedle-mediated transdermal delivery of sildenafil citrate from direct-compressed tablet reservoir for potential improvement of pulmonary hypertension therapy[J].Int Pharm,2023,631:122549.
[13] YADAV P R,DAS D B,PATTANAYEK S K.Coupled diffusion-binding-deformation modelling for phase-Transition microneedles-based drug dlivery[J].Pharm Sci,2023,112(4):1108-1118.
[14] AZIZ A,HASIR N A,IMRAN N,et al.Development of hydrogel-forming microneedles for transdermal delivery of albendazole from liquid reservoir[J].Biomater Sci Polym Ed,2023,34(8):1101-1120.
[15] ELIM D,FITRI A,MAHFUD M,et al.Hydrogel forming microneedle-mediated transdermal delivery of sildenafil citrate from polyethylene glycol reservoir:An ex vivo proof of concept study[J].Colloids Surf B Biointerfaces,2023,15(2):222-228.
[16] 王梅.口服天然黄体酮给药系统的设计[D].乌鲁木齐:新疆医科大学,2008.
[17] 由子樱,伍彦霖,孙一民,等.搭载米诺环素-壳聚糖纳米粒复合水凝胶用于牙周炎治疗的初步研究[J].华西口腔医学杂志,2023,41(1):11-20.
[18] 强娜,刘珠,冯颖,等.GelMA/PBS复合水凝胶的制备及性能研究[J].化工新型材料,2022,50(1):341-345.
基本信息:
中图分类号:R943
引用信息:
[1]贺宏吉,沈琪,王昭志,等.黄体酮脂质体微针的制备及体外性质考察[J].新疆医科大学学报,2023,46(10):1369-1375.
基金信息:
新疆维吾尔自治区自然科学基金项目(2021D01C287); 新疆维吾尔自治区重大科技专项项目(2022A03007-4)
2023-10-15
2023-10-15